Table 1 Demographic, Clinical, and Laboratory Characteristic of Subjects
Characteristics | Proportion (%) | Mean ± SD/Median (IQR) |
|---|---|---|
Age (years) | 62.33 ± 12.28 | |
Gender Man Woman | 43 (59.7%) 29 (40.3%) | |
Episode stroke New strokes Recurrent strokes | 51 (70.8%) 21 (29.2%) | |
Stroke type Ischemic stroke/NHS Hemorrhagic stroke/HS | 65 (90.3%) 7 (9.7%) | |
History of smoking | 8 (11.1%) | |
History of hypertension | 46 (63.9%) | |
History of DM | 32 (44.4%) | |
History of cardiac disease | 16 (22.2%) | |
History of Dyslipidemia | 13 (18.1%) | |
History of renal insufficiency | 19 (26.4%) | |
Systolic (mmHg) | 141. 04 ± 28.63 | |
Diastolic (mmHg) | 83.51 ± 17.73 | |
Quantitative GCS (score) | 15 (10–15) | |
Loss of consciousness | 33 (45.8%) | |
Motor deficit | 52 (72.2%) | |
Aphasia | 18 (25%) | |
Cranial nerve paresis | 37 (51.4%) | |
Focal Seizures | 2 (2.8%) | |
Generalized seizures | 6 (8.3%) | |
Severity of COVID-19 Mild Moderate Severe | 6 (8.3%) 28 (38.9%) 38 (52.8%) | |
Hemoglobin (g/dl) | 13.5 (11.65–15.35) | |
Erythrocyte (106/µL) | 4.61 ± 1.09 | |
Leukocytes (103/µL) | 10.05 (7.39–12.74) | |
Neutrophils (103/µL) | 8.14 (5.59–10.69) | |
Lymphocytes (103/µL) | 1.06 (0.66–1.46) | |
NLR | 7.69 (3.94–11.45) | |
Monocytes (103/µL) | 0.57 (0.29–0.85) | |
Eosinophils (103/µL) | 0 (0–0.04) | |
Basophils (103/µL) | 0.01 (0–0.11) | |
Platelets (103/µL) | 263.81 ± 122.09 | |
PT (seconds) | 15.85 (14.35–17.35) | |
APTT (seconds) | 35.65 (29.25–42.05) | |
INR | 1.17 (1.06–1.29) | |
D-Dimer (ng/mL) | 1182.5 (99–3276) | |
CRP (mg/dl) | 92.5 (35–150) | |
LDH (U/L) | 317.5 (211–424) | |
Albumin (g/dL) | 3.27 ± 30.50 | |
BUN (mg/dL) | 23.4 (5.88–40.93) | |
Creatinine (mg/dL) | 1.31 (0.80–1.82) | |
RBG (mg/dl) | 135 (42–228) | |
Sodium | 136.5 (133–140) | |
Potassium | 4.31 ± 0.88 | |
Chloride | 102 (98.5–105.5) | |
SGOT (U/L) | 42.5 (21.5–63.5) | |
SGPT (U/L) | 26.5 (12.5–40.5) | |
Respiratory Distress | 41 (56.9%) | |
Length Of Stay (LOS) | 5.5 (2–9) | |
Mortality | ||
Survive | 30 (41.7%) | |
Dead | 42 (58.3%) |